Prosensa Provides Update on Drisapersen
01 mai 2014 06h58 HE
|
Prosensa Holding N.V.
Leiden, The Netherlands, May 1, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) the Dutch
biopharmaceutical company focusing on rare diseases with a high
unmet medical need, yesterday...
Prosensa to Present at the 66th Annual American Academy of Neurology (AAN) Annual Meeting and the 39th Annual Deutsche Bank Health Care Conference
28 avr. 2014 08h00 HE
|
Prosensa Holding N.V.
Leiden, The Netherlands, April 28, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) the Dutch biopharmaceutical
company focusing on rare diseases with a high unmet medical need,
today...
Prosensa to Appoint Michael Wyzga to Supervisory Board
08 avr. 2014 08h00 HE
|
Prosensa Holding N.V.
Leiden, The Netherlands, April 8, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the Dutch
biopharmaceutical company focusing on rare diseases with a high
unmet medical need, today...
Prosensa Announces Full Year 2013 Financial Results and Recent Corporate Developments
18 mars 2014 07h00 HE
|
Prosensa Holding N.V.
LEIDEN, The Netherlands, March 18, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (Nasdaq:RNA), the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high...
Prosensa Announces 48-Week Data from a U.S. Phase II Placebo-Controlled Study of Drisapersen in 51 DMD Boys
17 mars 2014 18h00 HE
|
Prosensa Holding N.V.
Chicago, IL, March 17, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the Dutch
biopharmaceutical company focusing on RNA-modulating therapeutics
for rare diseases with high unmet need,...
Prosensa to Present at Upcoming Investor Conferences
06 mars 2014 08h00 HE
|
Prosensa Holding N.V.
Leiden, The Netherlands, March 6, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) announced
today announced presentations at upcoming investor conferences.
Celia Economides, Senior...
Prosensa Holding N.V. to Webcast Conference Call Discussing Full Year 2013 Financial Results and Corporate Update on March 18, 2014
05 mars 2014 10h18 HE
|
Prosensa Holding N.V.
Leiden, The Netherlands, March 5, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) today announced that the
Company will host a conference call and live audio webcast on
Tuesday, March 18,...
Prosensa to Participate at Upcoming Investor Conferences
31 janv. 2014 09h16 HE
|
Prosensa Holding N.V.
Leiden, The Netherlands, Jan. 31, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) announced
today that it is schedule to participate at the following investor
conferences in...
Prosensa Reports Initial Findings from the Further Clinical Data Analyses of Drisapersen for the Treatment of Duchenne Muscular Dystrophy
16 janv. 2014 12h35 HE
|
Prosensa Holding N.V.
Leiden, The Netherlands, Jan. 16, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the Dutch biopharmaceutical
company focusing on RNA-modulating therapeutics for rare diseases
with high...
Prosensa to Provide Corporate Update to Key Stakeholders
13 janv. 2014 15h09 HE
|
Prosensa Holding N.V.
Leiden, The Netherlands, Jan. 13, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the Dutch biopharmaceutical
company focusing on RNA-modulating therapeutics for rare diseases
with high...